Popular Articles

More Camden, N.J., Residents Using Needle Exchange Programs
A pilot needle exchange program in Camden, N.J., - one of four in the state - "was off to a slow start" when it began 18 months ago, but "now, 976 drug users have registered with the program - more people than those at the other pilot sites in Atlantic City, Newark or Paterson," the Cherry Hill Courier-Post reports. "In Camden, 854 people are living with HIV/AIDS, the eighth-highest number among New Jersey municipalities, according to the latest data from the state Department of Health and Senior Services. About a third of them were infected by dirty needles," the Courier-Post reports. Bob Baxter, who oversees Newark"s program, said needle exchanges provide "the most immediate benefit at the cheapest cost," in reducing the spread of blood-borne diseases. "While there"s no way to count the number of people who are no longer sharing needles because of the program, organizers say they hope to see their success correlate to lowered communicable disease rates," the article states (Hirsch, 7/20).
generic viagra online
Addictive 'Spice Gold' Causes Withdrawal Syndrome
A clinical report from Dresden supports the impression that "Spice Gold" is strongly addictive. In the current edition of Deutsches Arzteblatt International (Dtsch Arzteblatt Int 2009: 106[27]: 464-7), Ulrich S. Zimmermann, from Dresden Technical University, and his colleagues describe a young man who developed physical withdrawal symptoms after regular consumption of this designer drug, accompanied by a dependence syndrome.
News of the day
Genzyme Receives Positive Opinion For European Approval Of Mozobil
Genzyme Corporation (Nasdaq: GENZ) announced that the European Medicines Agency"s Committee for Human Medicinal Products (CHMP) has adopted a positive opinion on the marketing authorization application for Mozobil ® (plerixafor injection).
Oncology

Nurses: Providing Angioplasty Patient Care In And Out Of The Cath Lab

TCT Symposium will feature strategies for nurses and technologists to improve care for angioplasty patients WHAT: The Cardiovascular Nurse and Technologist Symposium at TCT 2009 will examine the latest advances in interventional, pharmacologic and clinical/administrative strategies for the management of the cardiovascular patient: * Focus on the heart attack patient receiving PCI * Revascularization decisions * Management decisions regarding patients with drug-eluting stents * Leadership * Tough calls in clinical decision-making * Taking charge of your own health WHEN: September 21-22, 2009 WHERE: The Moscone Center, San Francisco, CA WHY: Nurses are on the front lines in and out of the cath lab, providing care for patients with cardiovascular disease, which kills more Americans every year than cancer, making it one of the country"s most significant health risks and a critical health topic for millions of people. This symposium will bring nurses and technologists up to speed on the latest advances in patient care. Featured topics will include: Registered Cardiovascular Invasive Specialists (RCIS) Review Course * Revascularization Decisions in Various Patient Groups (Multivessel Disease, Unprotected Left Main Disease, AMI, etc.) * Improving Door-to-Balloon Times: Translating Research into Practice * Bringing Surgery into the Cath Lab Suite * Elective PCI at Noncardiac Surgery Facilities HOW TO REGISTER: Cardiovascular nurses and technologists may register for the conference at: http://www.tctconference.com/attendee-services/register-now.html Judy Romero Cardiovascular Research Foundation


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):